Get started
IMMUNO-BIOLOGICAL LABORATORIES COIMMUNO-BIOLOGICAL LABORATORIES COIMMUNO-BIOLOGICAL LABORATORIES CO

IMMUNO-BIOLOGICAL LABORATORIES CO

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

4570 chart


Full chart

4570 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.60 B‬ JPY
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
20
Basic EPS (TTM)
25 JPY
Net income (FY)
‪186.69 M‬ JPY
Revenue (FY)
‪816.70 M‬ JPY
Shares float
‪7.24 M‬
Beta (1Y)
0.89

Employees


Employees (FY)
57
Change (1Y)
−3 −5.00%
Revenue / Employee (1Y)
‪94.67 K‬ JPY
Net income / Employee (1Y)
‪21.64 K‬ JPY

About IMMUNO-BIOLOGICAL LABORATORIES CO


Sector
Health Technology
Industry
Medical Specialties
Headquarters
Fujioka
Website
ibl-japan.co.jp
Founded
1982
ISIN
JP3921300004
FIGI
BBG000QWHD67
Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals. The Genetically Modified Silkworm segment sells products using the cocoon of genetically modified silkworm. The Testing segment offers prevention and diagnostic support on top of drug discovery and research support in lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics-related segment develops and manufactures cosmetic products containing Neosilk-Human Collagen I. The company was founded on September 9, 1982 and is headquartered in Fujioka, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4570 is 501 JPY — it has increased by 1.42% in the past 24 hours. Watch IMMUNO-BIOLOGICAL LABORATORIES CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange IMMUNO-BIOLOGICAL LABORATORIES CO stocks are traded under the ticker 4570.
4570 stock has fallen by −0.40% compared to the previous week, the month change is a −4.57% fall, over the last year IMMUNO-BIOLOGICAL LABORATORIES CO has showed a −10.54% decrease.
4570 reached its all-time high on Mar 8, 2013 with the price of 4,400 JPY, and its all-time low was 75 JPY and was reached on Mar 15, 2011. View more price dynamics on 4570 chart.
See other stocks reaching their highest and lowest prices.
4570 stock is 2.02% volatile and has beta coefficient of 0.89. Track IMMUNO-BIOLOGICAL LABORATORIES CO stock price on the chart and check out the list of the most volatile stocks — is IMMUNO-BIOLOGICAL LABORATORIES CO there?
Today IMMUNO-BIOLOGICAL LABORATORIES CO has the market capitalization of ‪4.60 B‬, it has increased by 1.44% over the last week.
Yes, you can track IMMUNO-BIOLOGICAL LABORATORIES CO financials in yearly and quarterly reports right on TradingView.
IMMUNO-BIOLOGICAL LABORATORIES CO is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
4570 net income for the last quarter is ‪20.16 M‬ JPY, while the quarter before that showed ‪51.35 M‬ JPY of net income which accounts for −60.75% change. Track more IMMUNO-BIOLOGICAL LABORATORIES CO financial stats to get the full picture.
No, 4570 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 57.00 employees. See our rating of the largest employees — is IMMUNO-BIOLOGICAL LABORATORIES CO on this list?
Like other stocks, 4570 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMUNO-BIOLOGICAL LABORATORIES CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMUNO-BIOLOGICAL LABORATORIES CO technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMUNO-BIOLOGICAL LABORATORIES CO stock shows the neutral signal. See more of IMMUNO-BIOLOGICAL LABORATORIES CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.